| Name | Title | Contact Details |
|---|
Kenzen is pioneering the next generation of personal health monitors and analytics designed to empower its users in the field of health, motion tracking and performance. Utilizing ground-breaking sensor technology initially developed for scientific and aerospace research in Switzerland, Kenzen produces a variety of personal health monitors that wirelessly report data in real time to mobile devices. This data empowers individuals to make critical health decisions when it matters most.
Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.
Tango2 is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bryan Health is a not-for-profit healthcare system with two acute care facilities in Lincoln, a critical access hospital in Crete, outpatient clinics, and a statewide network that provides sophisticated mobile diagnostic treatment and services to citiz...
American Society of Pain Educators is a Montclair, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.